Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2001
A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V
V Ramakrishnan, F DeGuzman, M Bao, et al.
The Journal of Clinical Investigation
|
January 1, 1991
An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice
J LaMarre, M A Hayes, G K Wollenberg, et al.
Cancer Treatment Reports
|
March 1, 1978
Phase I study of maytansine using a 3-day schedule
F Cabanillas, V Rodriguez, S W Hall, et al.
The Journal of Biological Chemistry
|
November 21, 2000
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets
E De Candia, S W Hall, S Rutella, et al.
Journal of Clinical Pharmacology
|
July 1, 1978
The pharmacokinetics of bleomycin in man
W G Kramer, S Feldman, A Broughton, et al.
Cancer Treatment Reports
|
October 1, 1978
Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion
P Salem, S W Hall, R S Benjamin, et al.
Cancer Research
|
February 1, 1979
Pharmacokinetics and disposition of 3-deazauridine in humans
J A Benvenuto, S W Hall, D Farquhar, et al.
Cancer Research
|
July 1, 1983
Human pharmacokinetics of a new acridine derivative, 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992)
S W Hall, J Friedman, S S Legha, et al.
Drug Metabolism Reviews
|
January 1, 1978
Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man
T L Loo, R S Benjamin, K Lu, et al.
Cancer Treatment Reports
|
December 1, 1982
Doxorubicin-DNA complex: a phase I clinical trial
S W Hall, R S Benjamin, M A Burgess, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2001
A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V
V Ramakrishnan, F DeGuzman, M Bao, et al.
The Journal of Clinical Investigation
|
January 1, 1991
An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice
J LaMarre, M A Hayes, G K Wollenberg, et al.
Cancer Treatment Reports
|
March 1, 1978
Phase I study of maytansine using a 3-day schedule
F Cabanillas, V Rodriguez, S W Hall, et al.
The Journal of Biological Chemistry
|
November 21, 2000
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets
E De Candia, S W Hall, S Rutella, et al.
Journal of Clinical Pharmacology
|
July 1, 1978
The pharmacokinetics of bleomycin in man
W G Kramer, S Feldman, A Broughton, et al.
Cancer Treatment Reports
|
October 1, 1978
Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion
P Salem, S W Hall, R S Benjamin, et al.
Cancer Research
|
February 1, 1979
Pharmacokinetics and disposition of 3-deazauridine in humans
J A Benvenuto, S W Hall, D Farquhar, et al.
Cancer Research
|
July 1, 1983
Human pharmacokinetics of a new acridine derivative, 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992)
S W Hall, J Friedman, S S Legha, et al.
Drug Metabolism Reviews
|
January 1, 1978
Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man
T L Loo, R S Benjamin, K Lu, et al.
Cancer Treatment Reports
|
December 1, 1982
Doxorubicin-DNA complex: a phase I clinical trial
S W Hall, R S Benjamin, M A Burgess, et al.
Page
of 7